New atrial fibrillation guideline: Modify risk, control rhythm, prevent progression.

IF 3.4 4区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cleveland Clinic Journal of Medicine Pub Date : 2025-05-01 DOI:10.3949/ccjm.92a.24067

Laura A Campbell, Jessica P Ammon, Rachana Kombathula, Naa'irah Muhammad, Christopher D Jackson

引用次数: 0

Abstract

The latest (2023) guideline on atrial fibrillation from the American College of Cardiology, American Heart Association, American College of Chest Physicians, and Heart Rhythm Society introduces a new staging system for the disease, emphasizes risk-factor modification, prioritizes rhythm control over rate control, and clarifies which patients should be considered for catheter ablation. It also delves deeper than earlier guidelines into calculations of risk of thrombosis when deciding whether to start anticoagulant therapy.

查看原文本刊更多论文

新的房颤指南：降低风险，控制心律，预防进展。

美国心脏病学会、美国心脏协会、美国胸科医师学会和心律学会的最新（2023）房颤指南引入了一种新的房颤分期系统，强调危险因素的改变，优先考虑心律控制而不是心率控制，并明确了哪些患者应该考虑导管消融。在决定是否开始抗凝治疗时，它也比早期的指南更深入地研究了血栓形成风险的计算。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cleveland Clinic Journal of Medicine 医学-医学：内科

CiteScore

3.80

自引率

0.00%

发文量

109

审稿时长

6-12 weeks

期刊介绍： The mission of Cleveland Clinic Journal of Medicine (CCJM) is to provide its readers with up-to-date, practical, clinical information relevant to internal medicine, cardiology, and related fields. Consistent with this mission, CCJM focuses on timely review articles and other content that has a continuing-education orientation rather than on original research or case reports. CCJM authors, drawn from Cleveland Clinic and other top medical institutions throughout the world, are asked to identify new findings that are changing the practice of medicine and to advise readers how to apply them in daily patient care. Authors are chosen for their experience, acquired through caring for patients, teaching other physicians, and researching clinical questions.